Yoshihito Ohhara Selected Research

Yoshihito Ohhara Research Topics

10	Neoplasms (Cancer) 01/2024 - 01/2015
3	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 01/2016
2	Thyroid Neoplasms (Thyroid Cancer) 07/2023 - 01/2018
2	Mouth Neoplasms (Oral Cancer) 05/2017 - 02/2016
2	Colorectal Neoplasms (Colorectal Cancer) 09/2016 - 01/2015
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Disease Progression 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 08/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Thromboembolism 01/2018
1	Malignant Pleural Effusion 01/2016
1	Adenocarcinoma 01/2016

4	ErbB Receptors (EGF Receptor)IBA 04/2023 - 01/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2023 - 01/2018
2	lenvatinibIBA 07/2023 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 04/2023 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 05/2017 - 02/2016
2	Bevacizumab (Avastin)FDA Link 01/2016 - 01/2015
1	B7-H1 AntigenIBA 01/2024
1	ParaffinIBA 01/2024
1	Formaldehyde (Formol)FDA Link 01/2024
1	AntibodiesIBA 04/2023
1	Interferon Type IIBA 04/2023
1	InterferonsIBA 04/2023
1	Cell-Free Nucleic AcidsIBA 04/2023
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	karyopherin alpha 2IBA 01/2022
1	beta Karyopherins (Importin-beta)IBA 01/2022
1	PlatinumIBA 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	LigandsIBA 01/2018
1	Pemetrexed (MTA)FDA Link 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	MagnesiumIBA 01/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2015
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2015